Beam Therapeutics Inc.

BEAMNASDAQHealthcareBiotechnology

$24.73- (-)1Y −4.11%

As of Oct 15, 2026 close

Market cap: $2.58B
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $20.23$38.26
Volume (live): -
Avg. volume (3M): 1.97M

Beam Therapeutics Inc. (BEAM) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Beam Therapeutics Inc. stock.

Analyst Consensus Rating

Investment consensus from 14 professional research analysts

Consensus Rating

Buy

Based on 14 unique analysts

(15 total ratings in last 90 days)

High Confidence∞:1 Buy/Sell

Average Price Target

$53.91

+117.99% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest BEAM Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 2, 2026	Unknown Analyst	Wells Fargo	Maintains	Buy	$70.00
Sep 9, 2026	Mara Goldstein	Clear Street	Reiterates	Buy	$37.00
Sep 9, 2026	Whitney Ijem	Canaccord Genuity	Reiterates	Buy	$78.00
Sep 9, 2026	David Nierengarten	Wedbush	Maintains	Buy	$65.00
Sep 9, 2026	Boris Peaker	JonesTrading	Reiterates	Buy	$35.00
Sep 9, 2026	Alec Stranahan	BofA Securities	Maintains	Buy	$43.00
Sep 8, 2026	Patrick Trucchio	HC Wainwright	Reiterates	Buy	$80.00
Sep 8, 2026	Sami Corwin	William Blair	Maintains	Buy	-
Sep 8, 2026	Alec Stranahan	BofA Securities	Maintains	Buy	$43.00
Sep 8, 2026	Ekta Bagri	Zacks Equity Research	Initiates Coverage	Buy	-
Aug 24, 2026	Ahan Chakraborty	Zacks Equity Research	Initiates Coverage	Hold	-
Aug 6, 2026	Brian Cheng	JP Morgan	Maintains	Buy	$44.00
Aug 5, 2026	Yanan Zhu	Wells Fargo	Maintains	Buy	$70.00
Aug 5, 2026	Luca Issi	RBC Capital	Reiterates	Hold	$26.00
Aug 5, 2026	Cory Kasimov	Evercore ISI Group	Maintains	Buy	$45.00

Unknown Analyst

Wells Fargo

BuyMaintains

$70.00

Oct 2

Mara Goldstein

Clear Street

BuyReiterates

$37.00

Sep 9

Whitney Ijem

Canaccord Genuity

BuyReiterates

$78.00

Sep 9

David Nierengarten

Wedbush

BuyMaintains

$65.00

Sep 9

Boris Peaker

JonesTrading

BuyReiterates

$35.00

Sep 9

Alec Stranahan

BofA Securities

BuyMaintains

$43.00

Sep 9

Patrick Trucchio

HC Wainwright

BuyReiterates

$80.00

Sep 8

Sami Corwin

William Blair

BuyMaintains

Sep 8

Alec Stranahan

BofA Securities

BuyMaintains

$43.00

Sep 8

Ekta Bagri

Zacks Equity Research

BuyInitiates Coverage

Sep 8

Ahan Chakraborty

Zacks Equity Research

HoldInitiates Coverage

Aug 24

Brian Cheng

JP Morgan

BuyMaintains

$44.00

Aug 6

Yanan Zhu

Wells Fargo

BuyMaintains

$70.00

Aug 5

Luca Issi

RBC Capital

HoldReiterates

$26.00

Aug 5

Cory Kasimov

Evercore ISI Group

BuyMaintains

$45.00

Aug 5

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 2, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for BEAM?

The analyst consensus rating for BEAM is Buy, based on the latest ratings from 14 analysts over the last 90 days.

What is the average price target for BEAM?

The average 12-month price target for BEAM is $53.91, representing an upside of 118.0% from the Oct 15, 2026 close of $24.73.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.